Industries
Medtech
Serving as strategic business partners to 350+ medical device and medtech companies around the world
Practices
Unparalleled access to the largest and most influential network of leading venture capitalists, financial institutions and others strategic partners that service the medical device industry
Regularly represent target companies opposite larger medical device/technology companies on strategic investments, corporate partnering and commercialization deals and M&A transactions
20%
Advised on 20% of medical device and medtech IPOs in the past 5 years for companies like Amedica, Intersect ENT, T2 Biosystems and TriVascular Technologies
275+
medical device and life sciences M&A transactions since 2010, including deals for Auxogyn, CardioMEMS, Medidata, Protein Simple and Volcano Corporation
230+
medical device and life sciences venture financings raising an aggregate of $7+ billion since 2015 for companies like EndoGastric Solutions, Avedro, CardioDx, Proteus Digital Health and SynCardia
Defend False Claims Act actions arising from patient safety and research misconduct, manufacturing deficiencies, federal and state anti-kickback law violations, and other relevant fraud and abuse laws led by local, state and federal civil and criminal government enforcers
100+
Experience in more than 100+ state, federal and international courts, arbitral forums and administrative bodies
5
Fellows of the American College of Trial Lawyers and 20+ former Assistant US Attorneys and Department of Justice lawyers within our team
Recognized by The American Lawyer as an honorable mention in its Litigation Department of the Year competition
History of litigating landmark, precedent-setting cases that establish industry-wide resolutions or new procedural protections for our clients
Deep US and global experience providing regulatory counseling and advice on FDA, fraud & abuse, corporate compliance, contractual relationships, Sunshine Laws, reimbursement, government program price reporting, healthcare data privacy, licensure and accreditation, health reform counseling, regulatory due diligences, MHRA and CE Marking
Advise all players in the evolving ecosystem, including payors, providers, LS companies, health IT and investors
As connectors to the ecosystem, we counsel clients on how to launch innovative products and services
Represent healthcare clients in connection with federal and state government investigations, inquiries, settlements and voluntary disclosures, leveraging subject matter expertise and litigation and negotiation experience
Counsel related to privacy and data protection, government contracts and government analytics practices provided by multidisciplinary team bolstered by industry-leading lawyers
Frequent contributors on groundbreaking regulatory topics at leading industry events, editorial boards and relevant media and publications
#1
Market leader in life sciences – #1 in IPOs, M&A transactions, venture financings and licensing
30+
One of the largest medical technology patent teams in the US with 30+ dedicated patent lawyers and professionals
PhDs, MDs and advanced degrees in physics, mechanical and electrical engineering, biomedical and chemical engineering, chemistry, and biology
31,000+
patents currently under our management worldwide
1,000+
IP due diligence reviews in life sciences and medical device deals/transactions
500+
One of the most active IP litigation practices in the US with 500+ cases in the last 5 years
Top law firm for PTAB proceedings
Specialized branding team provides guidance on selecting, clearing, protecting and obtaining regulatory approval for medical device names
350+
medtech companies represented around the world
Digital Health Track at BIO International Convention
Cooley has been involved since the beginning.
Group contacts
